Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Long-Term Corp Bond Idx ETF Vanguard | VCLT | Apr 19, 2024 | 74.31 | +0.16 |
Long-Term Govt Bond Idx ETF Vanguard | VGLT | Apr 19, 2024 | 56.01 | +0.32 |
Longboard Pharmaceuticals | LBPH | Apr 19, 2024 | 17.44 | -3.16 |
Longeveron | LGVN | Apr 19, 2024 | 1.92 | -4.48 |
Loop Industries | LOOP | Apr 19, 2024 | 2.58 | -3.01 |
Loop Media | LPTV | Apr 19, 2024 | 0.29 | +4.55 |
Lottery.com | LTRY | Apr 19, 2024 | 1.88 | -5.53 |
Lotus Technology | LOT | Apr 19, 2024 | 5.67 | 0.00 |
Louisiana-Pacific | LPX | Apr 19, 2024 | 72.11 | +0.13 |
Lovesac | LOVE | Apr 19, 2024 | 20.80 | +2.21 |
Lowes | LOW | Apr 19, 2024 | 230.24 | +0.63 |
LPL Financial | LPLA | Apr 19, 2024 | 262.59 | +1.09 |
LQR House | LQR | Apr 19, 2024 | 1.04 | -7.52 |
LSB Industries | LXU | Apr 19, 2024 | 8.05 | +1.13 |
LSI Industries | LYTS | Apr 19, 2024 | 14.70 | +5.08 |
Ltc Properties | LTC | Apr 19, 2024 | 31.80 | +0.38 |
Lucas GC | LGCL | Apr 19, 2024 | 2.60 | 0.00 |
Lucid Diagnostics | LUCD | Apr 19, 2024 | 0.80 | -0.31 |
Lucid Group | LCID | Apr 19, 2024 | 2.45 | +0.41 |
Lucy Scientific Discovery | LSDI | Apr 19, 2024 | 1.12 | -7.82 |
Lufax ADR | LU | Apr 19, 2024 | 4.34 | +1.64 |
Lululemon Athletica | LULU | Apr 19, 2024 | 352.47 | +1.43 |
Lulus Fashion Lounge | LVLU | Apr 19, 2024 | 1.16 | -2.52 |
Lumen Technologies | LUMN | Apr 19, 2024 | 1.31 | -0.76 |
Lument Finance Trust | LFT | Apr 19, 2024 | 2.38 | +0.85 |
Lument Finance Trust A Pref | LFT-A | Apr 19, 2024 | 19.44 | +1.14 |
Lumentum | LITE | Apr 19, 2024 | 41.74 | -1.65 |
Luminar Technologies A | LAZR | Apr 19, 2024 | 1.31 | +3.97 |
Lumos Pharma | LUMO | Apr 19, 2024 | 2.59 | -1.15 |
Luna Innovations | LUNA | Apr 19, 2024 | 2.77 | -1.07 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.